Back to search

Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells

Data up to Jan 2025

Published1997
Citations229
References40

Total Citations Per Year

Abstract

References (40)

Antibodies, a laboratory manual

1989 • 12,929 citations

Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine Family

1991 • 1,864 citations

Tumor Cell Interactions with the Extracellular Matrix During Invasion and Metastasis

1993 • 1,523 citations

H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

1988 • 1,050 citations

Role of integrins and other cell adhesion molecules in tumor progression and metastasis.

1993 • 668 citations

Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis

1993 • 606 citations

Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin

1991 • 560 citations

The biology of SPARC, a protein that modulates cell‐matrix interactions

1994 • 533 citations

Role of the alpha v beta 3 integrin in human melanoma cell invasion.

1992 • 414 citations

SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix.

1989 • 375 citations

Treatment and Prevention of Rat Glioblastoma by Immunogenic C6 Cells Expressing Antisense Insulin-Like Growth Factor I RNA

1993 • 328 citations

SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway.

1993 • 274 citations

Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.

1993 • 260 citations

Modulation of the Metastatic Activity of Melanoma Cells by Laminin and Fibronectin

1984 • 258 citations

SPARC is a source of copper-binding peptides that stimulate angiogenesis.

1994 • 247 citations

Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

1995 • 234 citations

Role of laminin receptor in tumor cell migration.

1987 • 227 citations

The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells.

1991 • 223 citations

Distribution of SPARC in normal and neoplastic human tissue.

1995 • 214 citations

Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production.

1990 • 178 citations

Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genes

1995 • 174 citations

Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.

1990 • 164 citations

The Expression of the Secreted Protein Acidic and Rich in Cysteine (SPARC) Is Associated with the Neoplastic Progression of Human Melanoma

1997 • 160 citations

Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.

1995 • 152 citations

The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion.

1993 • 147 citations

Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts

1993 • 139 citations

SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.

1996 • 135 citations

Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1.

1992 • 96 citations

Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix

1996 • 80 citations

High‐affinity and low‐affinity calcium binding and stability of the multidomain extracellular 40‐kDa basement membrane glycoprotein (BM‐40/SPARC/osteonectin)

1992 • 79 citations

Antisense approaches to cancer gene therapy.

1995 • 65 citations

Changes in Calcium and Collagen IV Binding Caused by Mutations in the EF Hand and Other Domains of Extracellular Matrix Protein BM-40 (SPARC, Osteonectin)

1994 • 63 citations

Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains.

1993 • 51 citations

Osteonectin/SPARC Regulates Cellular Secretion Rates of Fibronectin and Laminin Extracellular Matrix Proteins

1994 • 43 citations

Expression of Cathepsin D in Primary and Metastatic Human Melanoma and Dysplastic Nevi

1995 • 41 citations

Latent fibronectin‐degrading serine proteinase activity in N‐terminal heparin‐binding domain of human plasma fibronectin

1991 • 37 citations

Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene.

1994 • 35 citations

Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells

1992 • 28 citations

Comparative expression of the SPARC and stromelysin-3 genes in mammary tumours

1996 • 15 citations

Truncated fibronectin. An autologous growth-promoting substance secreted by renal carcinoma cells

1992 • 8 citations

Cited By (0)

Loading...
Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human… (1997) – Nature Medicine | Metascience Observatory Explorer